Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation?

Hypertension

Volumn 47, Issue 2, 2006, Pages 259-264

  Da Silva, Alexandre A ^a   Kuo, Jay J ^a   Tallam, Lakshmi S ^a   Liu, Jiankang ^a   Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Diet; Glucose; Heart rate; Hypertension; Insulin resistance; Leptin; Metabolism

Indexed keywords

MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR;

ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; BODY FAT; CALORIC INTAKE; CANNULA; CARDIOVASCULAR FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; HYPERLEPTINEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAVENOUS CATHETER; LATERAL BRAIN VENTRICLE; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; MEASUREMENT; METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TIME; WEIGHT GAIN;

ANIMALS; BLOOD PRESSURE; DIET; ENERGY INTAKE; INJECTIONS, INTRAVENTRICULAR; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MELATONIN; OBESITY; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 31944445866     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000198458.70351.e0     Document Type: Article

References (31)

1. Garrison RJ, Kannel WB, Stokes J, Castelli WP. Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med. 1987;16:235-251.
2. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625-633.
3. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30:619-623.
4. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270-278.
5. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46:2040-2043.
6. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409-414.
7. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension. 2002;39:496-501.
8. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW. Melanocortin receptors in leptin effects. Nature. 1997;390:349.
9. da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension. 2004;43:1312-1317.
10. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett. 1998;249:107-110.
11. Haynes WG, Morgon DA, Djalali A, Sivitz WI, Mark AL. Interaction between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33:542-547.
12. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci. 2003;23:5998-6004.
13. Kuo JJ, Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension. 2003;41:768-774.
14. Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension. 2004;43:370-375.
15. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002;20:1245-1250.
16. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med. 1995;1:1311-1314.
17. Mantzoros CS, Flier JS. Editorial: leptin as a therapeutic agent-trials and tribulations. J Clin Endocrinol Metab. 2000;85:4000-4002.
18. da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension. 2004;43:383-387.
19. Li G, Zhang Y, Wilsey JT, Scarpace PJ. Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J Endocrinol. 2004;182:123-132.
20. Hansen MJ, Schioth HB, Morris MJ. Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet. Brain Res. 2005;1039:137-145.
21. Tulipano G, Vergoni AV, Soldi D, Muller EE, Cocchi D. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet. J Endocrinol. 2004;183:289-298.
22. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533-2536.
23. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol. 2004;287:H414-H418.
24. Alonso-Gracia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: role of angiotensin II and adrenergic activity. Hypertension. 1996;28:1047-1054.
25. Wolf G. Neuropeptides responding to leptin. Nutr Rev. 1997;55:85-88.
26. Horvath TL. The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci. 2005;8:561-565.
27. Clegg DJ, Benoit SC, Air EL, Jackman A, Tso P, D'Alessio D, Woods SC, Seeley RJ. Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII. Endocrinology. 2003;144:2941-2946.
28. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest. 2001;108:1079-1085.
29. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes. 2002;51:1337-1345.
30. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes. 2005;54:2012-2018.
31. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. MC4R deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia and hyperleptinemia. Hypertension. 2005;46:326-332.